Table 3.
Demographic characteristics of the responder and non-responder groups.
| Responder group | Non-responder group | Responder vs. Non-responder P-values | |
|---|---|---|---|
| Number | 6 | 3 | |
| Sex (Men / Female) |
1/5 | 1/2 | 1 |
| Age | 75.17 ± 5.04 | 75.33 ± 7.37 | 1 |
| Disease duration (year) | 1.5 ± 1.64 | 4.3 ± 2.08 | 0.095 |
| Evan index (pre-ope) | 0.33 ± 0.02 | 0.35 ± 0.03 | 0.167 |
| MMSE (pre-ope) | 23.33 ± 4.08 | 25.67 ± 1.15 | 0.714 |
| FAB (pre-ope) | 12.83 ± 3.82 | 12.67 ± 4.16 | 0.905 |
| TMTA (pre-ope) | 106.83 ± 38.78 | 100.67 ± 15.18 | 1 |
| Fazekas scale | |||
| PVH | 2.50 ± 0.55 | 2 | 0.464 |
| DSWMH | 2.50 ± 0.55 | 2 | 0.464 |
MMSE, Mini-Mental Statement Examination; FAB, Frontal Assessment Battery; TMTA, Trail Making Test A; PVH, Periventricular hyperintensity; DSWMH, Deep and subcortical white matter hyperintensity.